Abstract
Glycogen synthase kinase (GSK-3β) has been implicated in the pathophysiology of mood disorders and schizophrenia. To examine its role in suicide, we determined GSK-3β messenger RNA (mRNA) in human postmortem brain from suicide and normal control subjects using quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) technique. We found that GSK-3β mRNA was highly abundant in almost all of the 12 brain areas we studied. We also found a significant age effect on GSK-3β and that GSK-3β mRNA level were significantly higher in prefrontal cortex (PFC) and hippocampus of teenage normal controls compared with adult normal controls and was significantly decreased in PFC of teenage suicide but not adult suicide victims compared with respective normal control subjects. The decrease observed in the mRNA levels in teenage suicide but not in adult suicide victims may represent a neurodevelopmentally associated decrease and may be important in the pathophysiology of teenage suicide.
Similar content being viewed by others
References
Moscicki EK, O’Carroll P, Rae DS, Locke BZ, Roy A, Regier DA (1988) Suicide attempts in the Epidemiologic Catchment Area Study. Yale J Biol Med 61:259–268
Minino AM, Smith BL (2001) Deaths: preliminary data for 2000. Natl Vital Stat Rep 49:1–40
Botsis AF, Soldatos CR, Stefanis CN (1997) Suicide: biopsychological approaches. Elsevier, Amsterdam
Harris EC, Barraclough B (1997) Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 170:205–228
Kessler RC, McGonagle KA, Zhao S et al (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8–19
Lönqvist J (2000) Psychiatric aspects of suicidal behavior: Depression. In: von Heeringen K, Hawton K (eds) The International Handbook of Suicide and Attempted Suicide. Wiley, Chichester, UK, pp 107–120
Moscicki E (1977) Identification of suicide risk factors using epidemiologic studies. Psychiatr Clin North Am 20:499–517
Regier DA, Farmer ME, Rae DS et al (1993) One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. Acta Psychiatr Scand 88:35–47
Gross-Isseroff R, Biegon A, Voet H, Weizman A (1998) The suicide brain: a review of postmortem receptor/transporter binding studies. Neurosci Biobehav Rev 22:653–661
Pandey GN, Dwivedi Y, Rizavi HS et al (2002) Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 159:419–429
Pacheco MA, Stockmeier C, Meltzer HY, Overholser JC, Dilley GE, Jope RS (1996) Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res 723:37–45
Dwivedi Y, Rao JS, Rizavi HS et al (2003) Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry 60:273–282
Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2002) mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims. Neuropsychopharmacology 27:499–517
Jope RS, Song L, Grimes CA et al (1998) Selective increases in phosphoinositide signaling activity and G protein levels in postmortem brain from subjects with schizophrenia or alcohol dependence. J Neurochem 70:763–771
Dwivedi Y, Rizavi HS, Shukla PK et al (2004) Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol Psychiatry 55:234–243
Pandey GN, Dwivedi Y, Pandey SC, Conley RR, Roberts RC, Tamminga CA (1997) Protein kinase C in the postmortem brain of teenage suicide victims. Neurosci Lett 228:111–114
Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Conley RR (2004) Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study. Arch Gen Psychiatry 61:685–693
Grimes CA, Jope RS (2001) The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65:391–426
Dale TC (1998) Signal transduction by the Wnt family of ligands. Biochem J 329(Pt 2):209–223
Wodarz A, Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59–88
Patapoutian A, Reichardt LF (2000) Roles of Wnt proteins in neural development and maintenance. Curr Opin Neurobiol 10:392–399
Behrens J, Jerchow BA, Wurtele M et al (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280:596–599
Moon RT, Brown JD, Torres M (1997) WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 13:157–162
Shaw PC, Davies AF, Lau KF et al (1998) Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genes. Genome 41:720–727
Woodgett JR (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 9:2431–2438
Beasley C, Cotter D, Khan N et al (2001) Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia. Neurosci Lett 302:117–120
Cotter D, Kerwin R, al-Sarraji S et al (1998) Abnormalities of Wnt signalling in schizophrenia—evidence for neurodevelopmental abnormality. Neuroreport 9:1379–1383
Kozlovsky N, Belmaker RH, Agam G (2000) Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am J Psychiatry 157:831–833
Nadri C, Dean B, Scarr E, Agam G (2004) GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients. Schizophr Res 71:377–382
Lesort M, Greendorfer A, Stockmeier C, Johnson GV, Jope RS (1999) Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain. J Neural Transm 106:1217–1222
Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93:8455–8459
Stambolic V, Ruel L, Woodgett JR (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6:1664–1668
Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G (1999) Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. J Clin Psychiatry 60(Suppl 2):27–39 discussion 40-1, 113-6
Salzman S, E.J., Clayton P, Winokur G (1983) Diagnostic Evaluation After Death (DEAD). National Institute of Mental Health Neuroscience Research Branch, Rockville
Spitzer RL, Williams JB, Gibbon M, First MB (1992) The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49:624–629
Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2003) Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60:804–815
Leroy K, Brion JP (1999) Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J Chem Neuroanat 16:279–293
Kozlovsky N, Nadri C, Agam G (2005) Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult. Eur Neuropsychopharmacol 15:1–11
Nadri C, Lipska BK, Kozlovsky N, Weinberger DR, Belmaker RH, Agam G (2003) Glycogen synthase kinase (GSK)-3beta levels and activity in a neurodevelopmental rat model of schizophrenia. Brain Res Dev Brain Res 141:33–37
Fradkin LG, Garriga G, Salinas PC, Thomas JB, Yu X, Zou Y (2005) Wnt signaling in neural circuit development. J Neurosci 25:10376–10378
Ciani L, Salinas PC (2005) WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nat Rev Neurosci 6:351–362
Bijur GN, Jope RS (2001) Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta. J Biol Chem 276:37436–37442
Pap M, Cooper GM (1998) Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 273:19929–19932
Mai L, Jope RS, Li X (2002) BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J Neurochem 82:75–83
Manji HK, Moore GJ, Chen G (2000) Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry 61(Suppl 9):82–96
Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H (2004) Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry 55:781–784
Beasley C, Cotter D, Everall I (2002) An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder. Schizophr Res 58:63–67
Karege F, Perroud N, Burkhardt S et al (2007) Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry 61:240–245
Jope RS (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24:441–443
Acknowledgements
This work was supported by a grant RO1 MH 48153 (Dr. Pandey) and KO1 MH 01836 and RO1 MH 068777 (Dr. Dwivedi) and R01 MH60744 (Dr. Roberts) from the National Institute of Mental Health, Rockville, MD; and by a Distinguished Investigator grant (Dr. Pandey) and a Standard Research grant from the American Foundation for Suicide Prevention, New York, NY (Dr. Dwivedi) and a grant from NARSAD (Dr. Dwivedi). We thank Barbara Brown, B.S., and Miljana Petkovic, B.S., for their help in organizing the brain tissue. We also thank the members of the Maryland Brain Collection at the Maryland Psychiatric Research Center for their efforts, particularly in family interviews and dissection. We are grateful for the cooperation of Office of the Chief Medical Examiner.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pandey, G.N., Dwivedi, Y., Rizavi, H.S. et al. GSK-3β Gene Expression in Human Postmortem Brain: Regional Distribution, Effects of Age and Suicide. Neurochem Res 34, 274–285 (2009). https://doi.org/10.1007/s11064-008-9770-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-008-9770-1